This trial is testing whether or not progesterone affects testosterone levels in transwomen who are already taking estradiol as part of their gender affirming treatment. Participation will last for six months, during which time participants will have to give blood and take a pill once daily. There are no known risks for taking progesterone, but it may have benefits like increasing fat mass and breast size, and decreasing masculine hair patterns.
1 Primary · 6 Secondary · Reporting Duration: 24 weeks
20 Total Participants · 2 Treatment Groups
Primary Treatment: progesterone · Has Placebo Group · Phase 2
Age 18+ · Male Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|Saint Louis University||100.0%|